IP Library Granted Patent US 9,504,682
Granted Patent B2
US 9,504,682 · App. 13/970,650 · Granted Nov 29, 2016

Haptens of aripiprazole

Inventors: Ronghui Lin (Ambler, PA); Rhys Salter (Doylestown, PA); Thomas R. DeCory (Pittsford, NY); Eric Hryhorenko (Hilton, NY); Bart Remmerie (Ghent, BE); Banumathi Sankaran (Pittsford, NY)
Assignee: Janssen Pharmaceutica NV
A61K31/496A61K47/4833A61K47/48238A61K47/48284C07D215/22C07D215/227C07D401/12C07D401/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,504,682
App. No.
13/970,650
Granted
Nov 29, 2016
Kind
B2
Abstract

The invention relates to compounds of Formula I, wherein R 1 , R 2 , and R 3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.

Claims (55)

1. The compound of Formula I:

wherein:

R 1 is H,

CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

R 3 is H; provided that either R 1 or R 2 must be H, and further provided that R 1 and R 2 may not be H simultaneously;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

2. The compound of claim 1

wherein:

R 1 is H

CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

R 3 is H;

m is 1, 2, 3 or 4; and

n is 1, 2, 3, 4, or 5.

3. The compound of claim 1 wherein:

R 1 is H,

CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

NH 2 , or NHC(O)(CH 2 ) m CO 2 H;

R 3 is H, provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

4. The compound of claim 1

wherein:

R 1 is H

CH 2 NH 2 , CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H,

NH 2 , NHC(O)(CH 2 ) m CO 2 H;

provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

R 3 is H;

m is 1, 2, or 3; and

n is 1, 2, or 3.

5. The compound of claim 2 wherein:

R 1 is H, CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H, NH 2 , or NHC(O)(CH 2 ) n CO 2 H; provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

m is 1, 2 or 3; and

n is 1, 2 or 3.

6. The compound of claim 2

wherein:

R 1 is H, CH 2 NH 2 , or CH 2 NHC(O)(CH 2 ) m CO 2 H;

R 2 is H, NH 2 , or NHC(O)(CH 2 ) n CO 2 H; provided that either R 1 or R 2 must be H, and further provided that both R 1 and R 2 may not be H simultaneously;

m is 2; and

n is 2.

7. The compounds of claim 1 , selected from the group consisting of:

8. The compound of claim 7 which is

9. The compound of claim 7 which is

10. The compound of claim 7 which is

11. The compound of claim 7 which is

12. The compound of claim 7 which is

13. The compound of claim 7 which is

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2016
From: ORTHO-CLINICAL DIAGNOSTICS, INC.
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 039615/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2014
From: DECORY, THOMAS R.; HRYHORENKO, ERIC; SANKARAN, BANUMATHI
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 033668/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2014
From: REMMERIE, BART
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 033668/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2014
From: LIN, RONGHUI; SALTER, RHYS
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 033668/0631 →
Continuity (2)
Provisional Application 61691450 · Aug 21, 2012
Related Publication 20140163206A1 · Jun 12, 2014